Page last updated: 2024-10-21

phenytoin and Serotonin Syndrome

phenytoin has been researched along with Serotonin Syndrome in 1 studies

Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.

Research Excerpts

ExcerptRelevanceReference
"Lamotrigine is a novel anticonvulsant drug which also stabilises mood in bipolar illness via an unknown mechanism."1.30Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. ( Hagan, RM; Higgins, GA; Kirkby, D; Southam, E, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Southam, E1
Kirkby, D1
Higgins, GA1
Hagan, RM1

Other Studies

1 other study available for phenytoin and Serotonin Syndrome

ArticleYear
Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats.
    European journal of pharmacology, 1998, Sep-25, Volume: 358, Issue:1

    Topics: Acetates; Amines; Animals; Anticonvulsants; Biogenic Amines; Blood Platelets; Brain; Carbamazepine;

1998